
Meet our volunteers
Volunteers founded our charity in the 1970s and they continue to be at our heart.
Search results
Volunteers founded our charity in the 1970s and they continue to be at our heart.
Biotechnology company Kiora Pharmaceuticals has been given the go-ahead to start in-human testing of a novel “small molecule” treatment, known as KIO-301, for advanced vision loss in retinitis pigmentosa (RP). The phase 1b clinical trial will take place in Adelaide, Australia, and will begin enrolling participants towards the end of 2022.
Retina UK is delighted to have awarded a new three-year research grant to Prof Majlinda Lako at Newcastle University for a project entitled: To establish AAV.PRPF31 gene augmentation in PRPF31-deficient RPE and photoreceptor cells and assess its efficacy in restoring RPE and photoreceptor function.
After more than 10 years of service as Chair of the Board of Trustees, Don Grocott has retired.
We are proud to announce that Amar Latif - adventurer, entrepreneur, TV presenter and public speaker - is to join Retina UK as a volunteer ambassador.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Barcelona’s half marathon, also known as the Mitja Marato de Barcelona, is the second largest running event in Barcelona after the marathon.
17,000 runners from over 100 countries around the world are expected to take to the roads in March for the 2024 Barcelona Marathon
Is it your turn to take on the Reading Half Marathon in 2024?